Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinoma

Reliable biomarkers for renal cell carcinoma (RCC) have yet to be determined. Circulating tumor DNA (ctDNA) is an emerging resource to detect and monitor molecular characteristics of various tumors. The present study aims to clarify the clinical utility of ctDNA for RCC. Fifty‐three patients histolo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Yamamoto, Yoshiyuki, Uemura, Motohide, Fujita, Masashi, Maejima, Kazuhiro, Koh, Yoko, Matsushita, Makoto, Nakano, Kosuke, Hayashi, Yujiro, Wang, Cong, Ishizuya, Yu, Kinouchi, Toshiro, Hayashi, Takuji, Matsuzaki, Kyosuke, Jingushi, Kentaro, Kato, Taigo, Kawashima, Atsunari, Ujike, Takeshi, Nagahara, Akira, Fujita, Kazutoshi, Imamura, Ryoichi, Nakagawa, Hidewaki, Nonomura, Norio
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6361573/
https://ncbi.nlm.nih.gov/pubmed/30536551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13906
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados